Health In Tech Net Income
| HIT Stock | 1.12 0.01 0.88% |
As of the 10th of February, Health In retains the risk adjusted performance of (0.11), and Market Risk Adjusted Performance of (2.12). Health In technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Health In Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 1.6889 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 771 K | 1.2 M | |
| Net Income | 771 K | 732.5 K | |
| Net Income Per Share | 0.01 | 0.02 | |
| Net Income Per E B T | 0.68 | 0.50 |
Health | Net Income | Build AI portfolio with Health Stock |
The evolution of Net Income for Health In Tech provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Health In compares to historical norms and industry peers.
Latest Health In's Net Income Growth Pattern
Below is the plot of the Net Income of Health In Tech over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Health In Tech financial statement analysis. It represents the amount of money remaining after all of Health In Tech operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Health In's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Health In's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 670.48 K | 10 Years Trend |
|
Net Income |
| Timeline |
Health Net Income Regression Statistics
| Arithmetic Mean | 361,060 | |
| Geometric Mean | 148,158 | |
| Coefficient Of Variation | 175.77 | |
| Mean Deviation | 430,251 | |
| Median | 79,742 | |
| Standard Deviation | 634,641 | |
| Sample Variance | 402.8B | |
| Range | 2.4M | |
| R-Value | 0.57 | |
| Mean Square Error | 290.3B | |
| R-Squared | 0.32 | |
| Significance | 0.02 | |
| Slope | 71,558 | |
| Total Sum of Squares | 6.4T |
Health Net Income History
Other Fundumenentals of Health In Tech
Health In Net Income component correlations
Health Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Health In is extremely important. It helps to project a fair market value of Health Stock properly, considering its historical fundamentals such as Net Income. Since Health In's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Health In's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Health In's interrelated accounts and indicators.
Click cells to compare fundamentals
Is there potential for Insurance Brokers market expansion? Will Health introduce new products? Factors like these will boost the valuation of Health In. Market participants price Health higher when confident in its future expansion prospects. Understanding fair value requires weighing current performance against future potential. All the valuation information about Health In listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.103 | Earnings Share 0.02 | Revenue Per Share | Quarterly Revenue Growth 0.904 | Return On Assets |
Health In Tech's market price often diverges from its book value, the accounting figure shown on Health's balance sheet. Smart investors calculate Health In's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Health In's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Health In's value and its price as these two are different measures arrived at by different means. Investors typically determine if Health In is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Health In's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Health In 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Health In's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Health In.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Health In on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Health In Tech or generate 0.0% return on investment in Health In over 90 days. Health In is related to or competes with Expensify, Viant Technology, TROOPS, X3 Holdings, Teads BV, Robot Consulting, and Silvaco Group. Hitachi, Ltd. manufactures and sells electronic and electrical solutions primarily in Asia, North America, and Europe. More
Health In Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Health In's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Health In Tech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.16) | |||
| Maximum Drawdown | 30.57 | |||
| Value At Risk | (14.21) | |||
| Potential Upside | 11.2 |
Health In Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Health In's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Health In's standard deviation. In reality, there are many statistical measures that can use Health In historical prices to predict the future Health In's volatility.| Risk Adjusted Performance | (0.11) | |||
| Jensen Alpha | (1.20) | |||
| Total Risk Alpha | (1.99) | |||
| Treynor Ratio | (2.13) |
Health In February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | (2.12) | |||
| Mean Deviation | 5.45 | |||
| Coefficient Of Variation | (662.26) | |||
| Standard Deviation | 7.59 | |||
| Variance | 57.53 | |||
| Information Ratio | (0.16) | |||
| Jensen Alpha | (1.20) | |||
| Total Risk Alpha | (1.99) | |||
| Treynor Ratio | (2.13) | |||
| Maximum Drawdown | 30.57 | |||
| Value At Risk | (14.21) | |||
| Potential Upside | 11.2 | |||
| Skewness | (0.17) | |||
| Kurtosis | 2.13 |
Health In Tech Backtested Returns
Health In Tech holds Efficiency (Sharpe) Ratio of -0.0809, which attests that the entity had a -0.0809 % return per unit of standard deviation over the last 3 months. Health In Tech exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Health In's risk adjusted performance of (0.11), and Market Risk Adjusted Performance of (2.12) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 0.54, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Health In's returns are expected to increase less than the market. However, during the bear market, the loss of holding Health In is expected to be smaller as well. At this point, Health In Tech has a negative expected return of -0.56%. Please make sure to check out Health In's information ratio, as well as the relationship between the potential upside and rate of daily change , to decide if Health In Tech performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.36 |
Below average predictability
Health In Tech has below average predictability. Overlapping area represents the amount of predictability between Health In time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Health In Tech price movement. The serial correlation of 0.36 indicates that just about 36.0% of current Health In price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.36 | |
| Spearman Rank Test | 0.29 | |
| Residual Average | 0.0 | |
| Price Variance | 0.06 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Health Net Interest Income
Net Interest Income |
|
Based on the recorded statements, Health In Tech reported net income of 670.48 K. This is 99.88% lower than that of the Insurance sector and 99.45% lower than that of the Financials industry. The net income for all United States stocks is 99.88% higher than that of the company.
Health Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Health In's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Health In could also be used in its relative valuation, which is a method of valuing Health In by comparing valuation metrics of similar companies.Health In is currently under evaluation in net income category among its peers.
Health Fundamentals
| Return On Equity | 0.12 | ||||
| Return On Asset | 0.0533 | ||||
| Profit Margin | 0.05 % | ||||
| Operating Margin | 0.06 % | ||||
| Current Valuation | 51.89 M | ||||
| Shares Outstanding | 45.21 M | ||||
| Shares Owned By Insiders | 74.57 % | ||||
| Shares Owned By Institutions | 3.91 % | ||||
| Number Of Shares Shorted | 463.18 K | ||||
| Price To Earning | 24.13 X | ||||
| Price To Book | 3.48 X | ||||
| Price To Sales | 1.94 X | ||||
| Revenue | 19.49 M | ||||
| Gross Profit | 20.61 M | ||||
| EBITDA | 1.93 M | ||||
| Net Income | 670.48 K | ||||
| Cash And Equivalents | 7.05 B | ||||
| Cash Per Share | 15.61 X | ||||
| Total Debt | 206.69 K | ||||
| Debt To Equity | 1.14 % | ||||
| Current Ratio | 1.17 X | ||||
| Book Value Per Share | 0.30 X | ||||
| Cash Flow From Operations | 2.18 M | ||||
| Short Ratio | 0.98 X | ||||
| Earnings Per Share | 0.02 X | ||||
| Target Price | 4.5 | ||||
| Number Of Employees | 73 | ||||
| Beta | 1.04 | ||||
| Market Capitalization | 59.75 M | ||||
| Total Asset | 15.77 M | ||||
| Retained Earnings | 3.94 M | ||||
| Working Capital | 8.65 M | ||||
| Current Asset | 59.12 B | ||||
| Current Liabilities | 49.33 B | ||||
| Net Asset | 15.77 M |
About Health In Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Health In Tech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Health In using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Health In Tech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Health Stock Analysis
When running Health In's price analysis, check to measure Health In's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Health In is operating at the current time. Most of Health In's value examination focuses on studying past and present price action to predict the probability of Health In's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Health In's price. Additionally, you may evaluate how the addition of Health In to your portfolios can decrease your overall portfolio volatility.